Cargando…
Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model
Over the last decade, we have seen tremendous progress in research on 2-deoxy-D-glucose (2-DG) and its analogs. Clinical trials of 2-DG have demonstrated the challenges of using 2-DG as a monotherapy, due to its poor drug-like characteristics, leading researchers to focus on improving its bioavailab...
Autores principales: | Pająk, Beata, Siwiak-Niedbalska, Ewelina, Jaśkiewicz, Anna, Sołtyka, Maja, Zieliński, Rafał, Domoradzki, Tomasz, Fokt, Izabela, Skóra, Stanisław, Priebe, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698815/ https://www.ncbi.nlm.nih.gov/pubmed/34944565 http://dx.doi.org/10.3390/biomedicines9121749 |
Ejemplares similares
-
WP1234—A Novel Anticancer Agent with Bifunctional Activity in a Glioblastoma Model
por: Pająk, Beata, et al.
Publicado: (2022) -
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
por: Pajak, B., et al.
Publicado: (2019) -
Experimental and Computational Studies on Structure and Energetic Properties of Halogen Derivatives of 2-Deoxy-D-Glucose
por: Ziemniak, Marcin, et al.
Publicado: (2021) -
The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses
por: Pająk, Beata, et al.
Publicado: (2022) -
Targeting the JAK2/STAT3 Pathway—Can We Compare It to the Two Faces of the God Janus?
por: Jaśkiewicz, Anna, et al.
Publicado: (2020)